Scientific Research An Academic Publisher
OPEN ACCESS
Add your e-mail address to receive free newsletters from SCIRP.
Select Journal AA AAD AAR AASoci AAST ABB ABC ABCR ACES ACS ACT AD ADR AE AER AHS AID AiM AIT AJAC AJC AJCC AJCM AJIBM AJMB AJOR AJPS ALAMT ALC ALS AM AMI AMPC ANP APD APE APM ARS ARSci AS ASM BLR CC CE CellBio ChnStd CM CMB CN CRCM CS CSTA CUS CWEEE Detection EMAE ENG EPE ETSN FMAR FNS GEP GIS GM Graphene GSC Health IB ICA IIM IJAA IJAMSC IJCCE IJCM IJCNS IJG IJIDS IJIS IJMNTA IJMPCERO IJNM IJOC IJOHNS InfraMatics JACEN JAMP JASMI JBBS JBCPR JBiSE JBM JBNB JBPC JCC JCDSA JCPT JCT JDAIP JDM JEAS JECTC JEMAA JEP JFCMV JFRM JGIS JHEPGC JHRSS JIBTVA JILSA JIS JMF JMGBND JMMCE JMP JPEE JQIS JSBS JSEA JSEMAT JSIP JSS JSSM JST JTR JTST JTTs JWARP LCE MC ME MI MME MNSMS MPS MR MRC MRI MSA MSCE NJGC NM NR NS OALib OALibJ ODEM OJA OJAB OJAcct OJAnes OJAP OJApo OJAppS OJAPr OJAS OJBD OJBIPHY OJBM OJC OJCB OJCD OJCE OJCM OJD OJDer OJDM OJE OJEE OJEM OJEMD OJEpi OJER OJF OJFD OJG OJGas OJGen OJI OJIC OJIM OJINM OJL OJM OJMC OJMetal OJMH OJMI OJMIP OJML OJMM OJMN OJMP OJMS OJMSi OJN OJNeph OJO OJOG OJOGas OJOp OJOph OJOPM OJOTS OJPathology OJPC OJPChem OJPed OJPM OJPP OJPS OJPsych OJRA OJRad OJRD OJRM OJS OJSS OJSST OJST OJSTA OJTR OJTS OJU OJVM OPJ POS PP PST PSYCH SAR SCD SGRE SM SN SNL Soft SS TEL TI UOAJ VP WET WJA WJCD WJCMP WJCS WJET WJM WJNS WJNSE WJNST WJV WSN YM
More>>
Davidson, B., Trope, C.G. and Reich, R. (2014) The Clinical and Diagnostic Role of microRNAs in Ovarian Carcinoma. Gynecologic Oncology, 133, 640-646. http://dx.doi.org/10.1016/j.ygyno.2014.03.575
has been cited by the following article:
TITLE: Current Possible Drug Therapies for Ovarian Cancer
AUTHORS: Jungyeob Seoung, Young-Han Park, Chaechun Rhim, Sungju Kim
KEYWORDS: Ovarian Cancer, Intraperitoneal Chemotherapy, Targeting Therapy
JOURNAL NAME: Journal of Cancer Therapy, Vol.5 No.13, November 7, 2014
ABSTRACT: Ovarian cancer is the most aggressive gynecologic cancer of the heterogenous phenotypes. Development of the new chemotherapeutic agents and drug delivery mode makes better outcomes for patient treatments. Optimal cytoreductive therapy followed by molecular targeting therapy, intraperitoneal chemotherapy and dose dense chemotherapy is a hot therapeutic concept in ovarian cancers. In our review, we will introduce recent therapeutic advances in epithelial ovarian cancer patients.
Related Articles:
Merkel Cell Carcinoma of Eyelid: A Rare Clinical Presentation and Diagnostic Challenge
Manpreet Singh, Swati Singh, Usha Singh, Zoramthara Zadeng
DOI: 10.4236/ojoph.2013.31005 3,305 Downloads 5,141 Views Citations
Pub. Date: February 27, 2013
Oncoplastic Breast Surgery in Gynecologic Oncology Breast Pole to the National Institute of Rabat
J. A. M’bongo, Y. El Alami, W. L. Tatsipie Meukem, F. Tijami, Z. Hanchi, H. Hachi
DOI: 10.4236/ojog.2019.97097 426 Downloads 735 Views Citations
Pub. Date: July 22, 2019
Diagnosis of Acute Appendicitis in Adults: Role of a Simple Clinical Diagnostic Triad
Kassem Alubaidi, Malik Aikoye, P. S. Basnyat
DOI: 10.4236/ss.2016.74026 2,549 Downloads 3,687 Views Citations
Pub. Date: April 15, 2016
MicroRNAs as Targets and Tools in B-Cell Lymphoma Therapy
Kalman Szenthe, Katalin Nagy, Krisztina Buzas, Hans Helmut Niller, Janos Minarovits
DOI: 10.4236/jct.2013.43A057 3,413 Downloads 5,357 Views Citations
Pub. Date: March 25, 2013
Clinical Significance of Serum Galectin-1 and Its Tissue Immunohistochemical Expression in Serous Ovarian Carcinoma Patients
Mai Mohamed Abdelwahab, Huda Fathy Ebian, Taiseer Refat Ibrahim, Mohammad Samir Badr, Mohamed El-Bakry Lashin, Mahmoud Abdou Yassin, Adel Mohamed Ismail, Ahmed Ali Obaya
DOI: 10.4236/ojog.2019.97091 296 Downloads 542 Views Citations
Pub. Date: July 5, 2019
